Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple kit ease sexual pain for millions with endometriosis?

NCT ID NCT07683468

Symptom relief Sponsor: Elsan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether a specialized kit helps women with endometriosis manage pain during sex. The kit includes a guidebook, a tracking app, a TENS device, lubricants, and supplements. One hundred women aged 18 to 45 with confirmed endometriosis and sexual pain will either use the kit or receive standard care for three months. The goal is to see if the kit improves sexual quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
specialized kit (Endo-Sexo Guide, Endo Doute app, TENS device, penis rings, hyaluronic acid suppositories, CBD lubricant, CBD oil, PEA supplement, herbal supplement)
What this could lead to
If effective, this kit could give women with endometriosis a practical, non-drug way to reduce sexual pain and improve their quality of life.
What could go wrong
This is a small, single-center study with no blinding, so results may not apply broadly. The kit includes many components, making it hard to know which ones work.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 18 to 45 * Sexually active within the past 3 months * Confirmed diagnosis of endometriosis * Pain during sexual intercourse, as reported by the patient * Patients enrolled in or covered by the French social security system. * Patients who have been informed and have provided their free, informed, and written consent (no later than the day of enrollment and prior to any examination required for the study). Exclusion Criteria: * Patients participating in another interventional clinical trial for endometriosis. * Pregnant, breastfeeding, or laboring women * Patients who do not speak French or are unable to provide informed consent for the study * Patients with an allergy to any component of the study kit * Individuals who do not have a touchscreen mobile phone compatible with the Endo Doute app. * Participants whose physical and/or psychological health is severely impaired, which, in the investigator's opinion, may affect the participant's compliance with the study. * Participants currently in the exclusion period of another ongoing study at the time of enrollment. * Protected participants: adults under guardianship, conservatorship, or other legal protection; or individuals deprived of their liberty by judicial or administrative order.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endometriosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometriosis Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Endometriosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clinique de l'Estrée

    RECRUITING

    Stains, 93240, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.